Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 12Recruiting 6Unknown 3Terminated 3Active not recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 54Thoracic 17Gynecologic 15CNS 13Head & Neck 10Breast 9Sarcoma 7Genitourinary 3Dermatologic 3Other solid neoplasm 2Endocrine 2Tumor-Agnostic 1Other hematologic neoplasm 1NET 1Lymphoid 1

Conditions

Melanoma 2Uveal Melanoma 1Carcinoma, Basal Cell 1

Interventions

Nivolumab 27pembrolizumab 22Ipilimumab 17Temozolomide 13toripalimab 12Biopsy 10Cyclophosphamide 9Imiquimod 8Dacarbazine 7Blood Specimen Collection 7camrelizumab 6Chemotherapy, Adjuvant 6trametinib 5fludarabine 5dabrafenib 5atezolizumab 5aldesleukin 5Gene Expression Profiling 5Cisplatin 5Aminolevulinic Acid 5fludarabine phosphate 4durvalumab 4binimetinib 4apatinib 4Tomography, Optical Coherence 4Sorafenib 4Photochemotherapy 4Interleukin-2 4Injections 4Carboplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Surgical Procedures, Operative × Dermatologic × Clear all
NCT06150144 2024-01-02

The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma

University of Aleppo

Phase 3 Unknown
40 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT02977052 2023-11-15

OpACIN-neo

The Netherlands Cancer Institute

Phase 2 Unknown
186 enrolled
Dermatologic

Melanoma

NCT05402059 2022-06-15

ISABELLA

MelanomaPRO, Russia

Unknown
1,570 enrolled
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡